Breaking
Novo Nordisk Launches Wegovy in China Before Eli Lilly, Capturing World's Largest Obesity MarketVanda Pharmaceuticals Launches NEREUS (Tradipitant) - First New Motion Sickness Drug in 40+ Years Now AvailableTakeda's TAK-881 Meets Primary Endpoint in Phase 2/3 Trial for Primary Immunodeficiency Disease
🌏 NMPA

Microbiome

Page 1 • 1 item

Unlock global microbiome market insights. Discover pharma R&D, investment trends, and regulatory updates for strategic decision-making.